AIMS/HYPOTHESIS: We investigated associations of allelic variations in the WFS1 gene with insulin secretion and risk of type 2 diabetes in a general population prospective study. METHODS: We studied 5,110 unrelated French men and women who participated in the prospective Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. Additional cross-sectional analyses were performed on 4,472 French individuals with type 2 diabetes and 3,065 controls. Three single nucleotide polymorphisms (SNPs) were genotyped: rs10010131, rs1801213/rs7672995 and rs734312. RESULTS: We observed statistically significant associations between the major alleles of the three variants and prevalent type 2 diabetes in the DESIR cohort at baseline. Cox analyses showed an association between the G-allele of rs10010131 and incident type 2 diabetes (HR 1.34, 95% CI 1.08-1.70, p = 0.007). Similar results were observed for the G-allele of rs1801213 and the A-allele of rs734312. The GGA haplotype was associated with an increased risk of diabetes as compared with the ACG haplotype (HR 1.26, 95% CI 1.04-1.42, p = 0.02). We also observed statistically significant associations of the three SNPs with plasma glucose, HbA(1c) levels and insulin secretion at baseline and throughout the study in individuals with type 2 diabetes or at risk of developing diabetes. However, no association was observed in those who remained normoglycaemic at the end of the follow-up. Associations between the three variants and type 2 diabetes were replicated in cross-sectional studies of type 2 diabetic patients in comparison with a non-diabetic control group. CONCLUSIONS/ INTERPRETATION: The most frequent haplotype at the haplotype block containing the WFS1 gene modulated insulin secretion and was associated with an increased risk of type 2 diabetes.
AIMS/HYPOTHESIS: We investigated associations of allelic variations in the WFS1 gene with insulin secretion and risk of type 2 diabetes in a general population prospective study. METHODS: We studied 5,110 unrelated French men and women who participated in the prospective Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. Additional cross-sectional analyses were performed on 4,472 French individuals with type 2 diabetes and 3,065 controls. Three single nucleotide polymorphisms (SNPs) were genotyped: rs10010131, rs1801213/rs7672995 and rs734312. RESULTS: We observed statistically significant associations between the major alleles of the three variants and prevalent type 2 diabetes in the DESIR cohort at baseline. Cox analyses showed an association between the G-allele of rs10010131 and incident type 2 diabetes (HR 1.34, 95% CI 1.08-1.70, p = 0.007). Similar results were observed for the G-allele of rs1801213 and the A-allele of rs734312. The GGA haplotype was associated with an increased risk of diabetes as compared with the ACG haplotype (HR 1.26, 95% CI 1.04-1.42, p = 0.02). We also observed statistically significant associations of the three SNPs with plasma glucose, HbA(1c) levels and insulin secretion at baseline and throughout the study in individuals with type 2 diabetes or at risk of developing diabetes. However, no association was observed in those who remained normoglycaemic at the end of the follow-up. Associations between the three variants and type 2 diabetes were replicated in cross-sectional studies of type 2 diabeticpatients in comparison with a non-diabetic control group. CONCLUSIONS/ INTERPRETATION: The most frequent haplotype at the haplotype block containing the WFS1 gene modulated insulin secretion and was associated with an increased risk of type 2 diabetes.
Authors: H Inoue; Y Tanizawa; J Wasson; P Behn; K Kalidas; E Bernal-Mizrachi; M Mueckler; H Marshall; H Donis-Keller; P Crock; D Rogers; M Mikuni; H Kumashiro; K Higashi; G Sobue; Y Oka; M A Permutt Journal: Nat Genet Date: 1998-10 Impact factor: 38.330
Authors: Katherine A Fawcett; Eleanor Wheeler; Andrew P Morris; Sally L Ricketts; Göran Hallmans; Olov Rolandsson; Allan Daly; Jon Wasson; Alan Permutt; Andrew T Hattersley; Benjamin Glaser; Paul W Franks; Mark I McCarthy; Nicholas J Wareham; Manjinder S Sandhu; Inês Barroso Journal: Diabetes Date: 2009-12-22 Impact factor: 9.461
Authors: T M Strom; K Hörtnagel; S Hofmann; F Gekeler; C Scharfe; W Rabl; K D Gerbitz; T Meitinger Journal: Hum Mol Genet Date: 1998-12 Impact factor: 6.150
Authors: S A Schäfer; K Müssig; H Staiger; F Machicao; N Stefan; B Gallwitz; H U Häring; A Fritsche Journal: Diabetologia Date: 2009-03-28 Impact factor: 10.122
Authors: Annemarie M Simonis-Bik; Giel Nijpels; Timon W van Haeften; Jeanine J Houwing-Duistermaat; Dorret I Boomsma; Erwin Reiling; Els C van Hove; Michaela Diamant; Mark H H Kramer; Robert J Heine; J Antonie Maassen; P Eline Slagboom; Gonneke Willemsen; Jacqueline M Dekker; Elisabeth M Eekhoff; Eco J de Geus; Leen M 't Hart Journal: Diabetes Date: 2009-10-15 Impact factor: 9.461
Authors: Christian Dina; David Meyre; Sophie Gallina; Emmanuelle Durand; Antje Körner; Peter Jacobson; Lena M S Carlsson; Wieland Kiess; Vincent Vatin; Cecile Lecoeur; Jérome Delplanque; Emmanuel Vaillant; François Pattou; Juan Ruiz; Jacques Weill; Claire Levy-Marchal; Fritz Horber; Natascha Potoczna; Serge Hercberg; Catherine Le Stunff; Pierre Bougnères; Peter Kovacs; Michel Marre; Beverley Balkau; Stéphane Cauchi; Jean-Claude Chèvre; Philippe Froguel Journal: Nat Genet Date: 2007-05-13 Impact factor: 38.330
Authors: Dimitry A Chistiakov; Dmitry S Khodyrev; Svetlana A Smetanina; Larisa N Bel'chikova; Lyudmila A Suplotova; Valery V Nosikov Journal: Rev Diabet Stud Date: 2011-02-10
Authors: N Franceschini; K Haack; H H H Göring; V S Voruganti; S Laston; L Almasy; E T Lee; L G Best; R R Fabsitz; K E North; J W Maccluer; J B Meigs; J S Pankow; S A Cole Journal: Diabetologia Date: 2013-07-14 Impact factor: 10.122
Authors: Stefan Johansson; Henrik Irgens; Kishan K Chudasama; Janne Molnes; Jan Aerts; Francisco S Roque; Inge Jonassen; Shawn Levy; Kari Lima; Per M Knappskog; Graeme I Bell; Anders Molven; Pål R Njølstad Journal: PLoS One Date: 2012-05-25 Impact factor: 3.240
Authors: Carolina Bonilla; Debbie A Lawlor; Yoav Ben-Shlomo; Andrew R Ness; David Gunnell; Susan M Ring; George Davey Smith; Sarah J Lewis Journal: BMC Med Genet Date: 2012-09-27 Impact factor: 2.103
Authors: Angela Lucariello; Angelica Perna; Carmine Sellitto; Alfonso Baldi; Alessandro Iannaccone; Luigi Cobellis; Antonio De Luca; Maria De Falco Journal: Biomed Res Int Date: 2014-01-23 Impact factor: 3.411
Authors: Claudia H T Tam; Janice S K Ho; Ying Wang; Vincent K L Lam; Heung Man Lee; Guozhi Jiang; Eric S H Lau; Alice P S Kong; Xiaodan Fan; Jean L F Woo; Stephen K W Tsui; Maggie C Y Ng; Wing Yee So; Juliana C N Chan; Ronald C W Ma Journal: PLoS One Date: 2013-12-20 Impact factor: 3.240